Literature DB >> 8739806

Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use.

N Magrini1, A Vaccheri, E Parma, R D'Alessandro, A Bottoni, M Occhionero, N Montanaro.   

Abstract

This study was conducted to determine the prevalence and profile of use of benzodiazepines in the Italian population and risk factors for use. Between November 1992 and February 1993, 62 general practitioners submitted a validated self-administered questionnaire on health status and drug use to a randomised sample of 3100 subjects ( > or = 18 years of age, stratified by sex and age), of whom 2803 responded (response, rate 90.4%). Main outcome measures were point estimate (past-week) of all the drugs taken by each individual, dosage and length of use and source of the prescription. The overall past-week prevalence of use of benzodiazepines was 8.6% (5.0% males and 11.8% females). In the elderly ( > or = 65 years) 18.8% reported current use (9.0% males and 24.7% females). Fifty-six per cent of the persons exposed to a benzodiazepine were chronic users (daily, for more than 6 months), and 70.1% in subjects > or = 65 years. The average daily dose taken was relatively low: 61% of short-term users and 51% of chronic users used less than half a defined daily dose (DDD). Female sex, older age, unemployment and retirement were independently associated with the use of benzodiazepines. Benzodiazepine use in Italy appeared to be relatively high (about 9% of subjects reported current use 57% of whom were chronic users). Women were prescribed a benzodiazepine twice as often as men and one out of four elderly women was on treatment. Although the average dosage used was rather low, the high prevalence and the elevated proportion of chronic users should encourage drug information campaigns and educational interventions to promote a more conservative use of these drugs especially in the elderly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739806     DOI: 10.1007/s002280050063

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Utilization of hypnotic medication in the context of cancer: predictors and frequency of use.

Authors:  Lucie Casault; Josée Savard; Hans Ivers; Marie-Hélène Savard; Sébastien Simard
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

2.  Patterns of psychotropic medicine use and related diseases across educational groups: national cross-sectional survey.

Authors:  Merete W Nielsen; Ebba Holme Hansen; Niels Kristian Rasmussen
Journal:  Eur J Clin Pharmacol       Date:  2004-03-16       Impact factor: 2.953

Review 3.  Opioid and benzodiazepine use in end-stage renal disease: a systematic review.

Authors:  Ahraaz Wyne; Raman Rai; Meaghan Cuerden; William F Clark; Rita S Suri
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 8.237

4.  Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition.

Authors:  Yuhai Zhang; Xiao-Hua Zhou; Dana H Meranus; Linbo Wang; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

5.  Mental disorders associated with benzodiazepine use among older primary care attenders--a regional survey.

Authors:  Matteo Balestrieri; Gabriella Marcon; Fabio Samani; Monica Marini; Emiliano Sessa; Umberto Gelatti; Francesco Donato
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-04       Impact factor: 4.328

6.  Prevalence and correlates of inappropriate use of benzodiazepines in Kosovo.

Authors:  Zejdush Tahiri; Suela Kellici; Iris Mone; Driton Shabani; Musa Qazimi; Genc Burazeri
Journal:  Int J Clin Pharm       Date:  2017-05-18

7.  Level and factors of benzodiazepines misuse in Albania.

Authors:  Suela Kellici; Ela Hoti; Genc Burazeri
Journal:  Int J Clin Pharm       Date:  2013-02-20

8.  Effects of legal and illegal use of benzodiazepines at acute admission to a psychiatric acute department.

Authors:  John C Fløvig; Arne E Vaaler; Gunnar Morken
Journal:  BMC Res Notes       Date:  2010-10-19

9.  Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.

Authors:  Nicholas T Vozoris; Hadas D Fischer; Xuesong Wang; Geoffrey M Anderson; Chaim M Bell; Andrea S Gershon; Anne L Stephenson; Sudeep S Gill; Paula A Rochon
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

10.  Determinants of chronic benzodiazepine use in the elderly: a longitudinal study.

Authors:  Hendrika J Luijendijk; Henning Tiemeier; Albert Hofman; Jan Heeringa; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.